5 Biotech Stocks With Breakthrough TreatmentsInvestors have been flocking to reap the benefits of rising biotech sector, with notable success within a particular sub-sector that has been under appreciated. Spanning the 6 month time frame from November 2017 to May 2018, the S&P 500 (SPY) has increased ~+2.7%. Within that time frame, SPDR S&P Biotech ETF (XBI) has gone up ~+5.3%. The ~2.6% difference in gains between the two offers only a slight glance at the health of the biotech sector. $XBI, SPDR Series Trust SPDR S&P Biotech ETF / H1 Within the sector, micro and small cap companies are the true rising stars largely responsible for bolstering the the sectors substantial gains, growth, and value. For example, Alps Medical Breakthroughs ETF (SBIO) exclusively holds micro and small cap biotech and health cares stocks and is ~+14.5% over the last 6th months. PowerShares S&P SmallCap Health Care Portfolio ETF (PSCH), another ETF filled exclusively with micro and small cap biotech and healthcare holdings, is ~+31.1%. Here is a recap of what investors should know about 5 breakthrough, small cap biotech/biopharma companies in May: See All 5 Biotech Stocks To Watch, CLICK HERE